Omniscan intelligence · 1 September 2026–30 September 2026

UK pharma media reputation tracker

Compare share of voice, sentiment and themes for GSK, AstraZeneca, Pfizer and 7 peers across 859 UK earned-media mentions, Sep–Sep 2026.

Reporting period: 1 September 2026–30 September 2026
Articles analysed: 929
Earned-media mentions: 859
Organisations compared: 10

Organisations in the benchmark

GSK
AstraZeneca
Pfizer
Eli Lilly
Novartis
MSD
Roche
Sanofi
Novo Nordisk
Moderna

What the benchmark compares

Explore share of voice, monthly visibility, coverage volume, positive and negative sentiment, net media tone and editorial themes. Compare the full cohort, then open an organisation-level deep dive for its news-cycle movement, leading themes and coverage evidence.

AstraZeneca led average share of voice at 30.8%.